Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4562 ARTÍCULOS , VIENDO DEL 1396 AL 1410

Long-term management of Parkinson's disease using levodopa combinations

Müller T, Möhr JD.

Expert Opin Pharmacother. 2018 Jun;19(9):1003-1011. doi: 10.1080/14656566.2018.1484108. Epub 2018 Jun 18.

Neuronal firing rate and oscillatory patterns in the basal ganglia nuclei differ from those of the ventrolateral thalamus in patients with Parkinson disease

Du G, Zhuang P, Zhang Y, Li J, Li Y.

Neurosci Lett. 2018 Sep 14;683:1-6. doi: 10.1016/j.neulet.2018.06.021. Epub 2018 Jun 18.

Progression of Cognitive Decline in Parkinson's Disease

Roheger M, Kalbe E, Liepelt-Scarfone I.

J Parkinsons Dis. 2018;8(2):183-193. doi: 10.3233/JPD-181306.

SPARC: a new approach to quantifying gait smoothness in patients with Parkinson's disease

Beck Y, Herman T, Brozgol M, Giladi N, Mirelman A, Hausdorff JM.

J Neuroeng Rehabil. 2018 Jun 18;15(1):49. doi: 10.1186/s12984-018-0398-3.

Network imaging biomarkers: insights and clinical applications in Parkinson's disease

Schindlbeck KA, Eidelberg D.

Lancet Neurol. 2018 Jul;17(7):629-640. doi: 10.1016/S1474-4422(18)30169-8.

A noninterventional study evaluating the effectiveness of rotigotine and levodopa combination therapy in younger versus older patients with Parkinson's disease

Woitalla D, Dunac A, Safavi A, Ceravolo MG, Gomez Esteban JC, Pavese N, Asgharnejad M, Joeres L, Schuller JC, Chaudhuri KR.

Expert Opin Pharmacother. 2018 Jun;19(9):937-945. doi: 10.1080/14656566.2018.1480721. Epub 2018 Jun 19.

Consistent decreased activity in the putamen in Parkinson's disease: a meta-analysis and an independent validation of resting-state fMRI

Wang J, Zhang JR, Zang YF, Wu T.

Gigascience. 2018 Jun 1;7(6):giy071. doi: 10.1093/gigascience/giy071.

Amygdala and emotionality in Parkinson's disease: An integrative review of the neuropsychological evidence

Trnka R, Hasto J, Cabelkova I, Kuska M, Tavel P, Nikolai T.

Neuro Endocrinol Lett. 2018 May;39(2):105-110.

Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders

Niazi ZR, Khan N, Khan S, Alam M, Kamal MA.

Protein Pept Lett. 2018;25(7):633-642. doi: 10.2174/0929866525666180614120407.

Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Neuroinflammation and Neuroplasticity in Patients with Parkinson's Disease: a Placebo-Controlled Study

Aftanas LI, Gevorgyan MM, Zhanaeva SY, Dzemidovich SS, Kulikova KI, Al'perina EL, Danilenko KV, Idova GV.

Bull Exp Biol Med. 2018 Jun;165(2):195-199. doi: 10.1007/s10517-018-4128-4. Epub 2018 Jun 19.

Genomic convergence of locus-based GWAS meta-analysis identifies AXIN1 as a novel Parkinson's gene

Saeed M.

Immunogenetics. 2018 Sep;70(9):563-570. doi: 10.1007/s00251-018-1068-0. Epub 2018 Jun 19.

Catheter radiofrequency ablation for arrhythmias under the guidance of the Carto 3 three-dimensional mapping system in an operating room without digital subtraction angiography

Huang X, Chen Y, Huang Z, He L, Liu S, Deng X, Wang Y, Li R, Xu D, Peng J.

Medicine (Baltimore). 2018 Jun;97(25):e11044. doi: 10.1097/MD.0000000000011044.

Unilateral acne after facial palsy

Sudy E, Urbina F.

An Bras Dermatol. 2018 Jun;93(3):441-442. doi: 10.1590/abd1806-4841.20187437.

Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases

Choi ML, Gandhi S.

FEBS J. 2018 Oct;285(19):3631-3644. doi: 10.1111/febs.14587. Epub 2018 Aug 21.

Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial

Hsu JH, Mulsant BH, Lenze EJ, Sanches M, Karp JF, Reynolds CF, Blumberger DM.

J Clin Psychiatry. 2018 Jun 19;79(4):17m11764. doi: 10.4088/JCP.17m11764.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias